Showing 281 - 300 results of 80,813 for search '(( 2 c decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (mean decrease)) ))', query time: 1.35s Refine Results
  1. 281

    Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice. by Udaysankar Chockanathan (18510288)

    Published 2024
    “…(B) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.132 ± 0.048, APP/PS1 = 0.128 ± 0.051, p < 0.005, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 305 units from 5 recording sessions, n<sub>APP/PS1</sub> = 180 units from 4 recording sessions). …”
  2. 282
  3. 283
  4. 284
  5. 285
  6. 286
  7. 287

    Knockdown of AR expression decreases the efficiency of KSHV infection in endothelial cells. by Xing Wang (154377)

    Published 2017
    “…The above cells were infected with KSHV for 2 h at 37°C, washed, and cultured for another 22 h, and the MOIs were 10 and 5 for HUVECs and SLK cells, respectively. …”
  8. 288

    Decrease in extracellular Zn<sup>2+</sup> in the hippocampus by zinc chelators. by Atsushi Takeda (18203)

    Published 2013
    “…<p>Hippocampal slices were prepared 2 h after i.p. injection of vehicle (A, n = 7) or CQ (30 mg/kg, B, n = 5) into NER, and 3 h after i.p. injection of vehicle (C, n = 7) or TPEN (1 mg/kg, D, n = 8) into NER. …”
  9. 289

    Spatial stability is decreased in APP/PS1 mice in both dCA1 and vCA1. by Udaysankar Chockanathan (18510288)

    Published 2024
    “…<p>(A) In dCA1, stability score was significantly decreased in APP/PS1 mice relative to C57BL/6 mice (mean ± std: C57BL/6 = -0.009 ± 0.292, APP/PS1 = -0.1845 ± 0.256, p < 10<sup>−6</sup>, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 295 units from 5 recording sessions, n<sub>APP/PS1</sub> = 167 units from 4 recording sessions). …”
  10. 290
  11. 291
  12. 292
  13. 293
  14. 294
  15. 295
  16. 296
  17. 297
  18. 298
  19. 299
  20. 300

    Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

    Published 2021
    “…(B) PBS treatment, composite from 2 sections (C) ATRA-treatment, single section (D) Clodronate liposome treatment, composite from 2 sections. …”